Self-retaining intraurethral device for treatment of prostatic obstruction.
We report our experience about insertion of 32 self-retaining intraurethral device (IUC) in patients with prostatic obstruction. Follow-up ranged between 2 and 38 weeks. Success rate of IUC insertion was 93.7% and 46.6% of patients have IUC in place without complications during follow-up. IUC is easy and quick to introduce, it allows spontaneous voiding, full continence, sexual activity and routine life-style. It represents a useful alternative to indwelling catheter in patients at high risk or refusing surgery and it might be used in patients who are waiting for surgery or need long term catheterization.
Cecchi
M
M
Department of Urology, University of Pisa, Italy.
Felipetto
R
R
Viganò
L
L
Minervini
R
R
Fiorentini
L
L
D000368:Aged; D002408:Catheters, Indwelling; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications*; D011471:Prostatic Neoplasms / Q000150:complications; D015607:Stents; D014524:Urethral Obstruction / Q000209:etiology / Q000628:therapy*; D014546:Urinary Catheterization / Q000295:instrumentation*